Where do Bristol-Myers Squibb's ratios come from?

Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	281.3%-10.5pp	281.3%-15.8pp	281.3%-20.9pp	286.7%-17.1pp	291.8%-13.7pp
Net margin	52.5%+89.3pp	48.7%+110pp	15.4%+40.4pp	-12.3%-21.0pp	-36.8%-77.2pp
EBITDA margin	108.5%+62.2pp	110.8%+85.0pp	85.2%+21.3pp	65.6%-32.4pp	46.3%-85.3pp
Free cash flow margin	113.6%+0.4pp	116.5%+3.3pp	118.8%+6.2pp	116%+6.6pp	113.3%+8.0pp
Returns
Return on equity	141.7%+208pp	134.4%+257pp	54.5%+112pp	-10.4%-11.7pp	-66%-119pp
Return on assets	27.4%+46.2pp	24.8%+55.6pp	7.5%+20.3pp	-6.6%-10.4pp	-18.8%-37.8pp
Return on invested capital	44.5%+72.0pp	40.2%+85.9pp	13%+30.2pp	-9%-17.0pp	-27.5%-59.3pp
Efficiency
Asset turnover	2.1×+0.1×	2×0.0×	2×+0.1×	2×+0.1×	2×+0.1×
Inventory turnover	20.3×-1.8×	20×-3.4×	20×-4.8×	20.9×-12.8×	22.1×-20.7×
Liquidity
Current ratio	5.1×+0.2×	5×+0.2×	5×+0.1×	5×+0.1×	4.9×-0.2×
Quick ratio	4.7×+0.3×	4.6×+0.3×	4.6×+0.2×	4.5×0.0×	4.4×-0.4×
Cash ratio	2×+0.4×	1.9×+0.5×	1.9×+0.4×	1.7×+0.2×	1.5×-0.1×
Leverage
Debt-to-equity	10.3×-1.7×	10.9×-1.6×	11.5×+0.7×	11.7×+2.5×	12×+4.6×
Debt-to-assets	2.1×-0.1×	2.1×-0.1×	2.1×0.0×	2.1×+0.2×	2.2×+0.3×
Net debt / EBITDA	10.9×-56.5×	11×-65.2×	47.3×+8.5×	57.4×+29.6×	67.4×+50.8×
Valuation
Market capitalization	$421.15B-1.6%	$421.42B+1.9%	$426.32B+5.7%	$439.42B+4.7%	$427.9B-8.9%
Enterprise value	$563.41B-5.5%	$567.6B-3.7%	$576.43B+1.5%	$598.09B+4.2%	$596.06B-2.1%
Price / earnings	67.2×—	73.4×—	——	——	——
Price / sales	8.8×-0.3×	8.8×0.0×	8.9×+0.1×	9.2×0.0×	9×-1.4×
Price / book	22.6×-2.7×	23.5×-1.2×	24.6×+3.3×	25.8×+6.4×	25.2×+6.6×
EV / EBITDA	43.1×-198×	42.7×-226×	180.4×+53.5×	215.1×+124×	241×+178×
EV / sales	11.7×-0.8×	11.9×-0.7×	12×-0.3×	12.5×-0.1×	12.5×-0.9×
Free cash flow yield	53.2%+2.0pp	54.1%+2.0pp	54.6%+2.5pp	51.1%+2.5pp	51.2%+10.1pp
Earnings yield	24%+42.2pp	22.4%+50.6pp	8.1%+20.8pp	-5.3%-6.4pp	-18.2%-33.1pp
Dividend yield	19.3%+0.9pp	19.2%+0.3pp	18.8%-0.3pp	18%-0.5pp	18.5%+2.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bristol-Myers Squibb.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Bristol-Myers Squibb's ratios come from?: Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.